Editor: Jean-Marc Sabatier

Coronaviruses

Volume 2

eBook: US $49 Special Offer (PDF + Printed Copy): US $84
Printed Copy: US $59
Library License: US $196
ISSN: 2737-5625 (Print)
ISSN: 2737-5633 (Online)
ISBN: 978-981-4998-61-1 (Print)
ISBN: 978-981-4998-60-4 (Online)
Year of Publication: 2021
DOI: 10.2174/97898149986041210201

Introduction

Scientific literature on SARS-COV-2 viruses and its variants (especially variants of concern such as the ‘Delta variant’) and important cellular targets is crucial to help researchers, epidemiologists, virologists and clinicians around the globe to develop a new generation of safer and more effective vaccines, and other treatments to address COVID-19 disease. The accompanying damage to the many organs and tissues of SARS-Co-2-infected people also needs to be understood and researchers are using data to devise meaningful protocols for treating these symptoms. This second volume of Coronaviruses brings together more useful information about the prevention, vaccination, and chemotherapies for the potential treatment of coronavirus infections. The volume includes eight chapters: (1) Broad spectrum antivirals to combat COVID-19 The reality and challenges, (2) COVID-19: Preventive and protective control management strategies, (3) Plant-derived extracts and bioactive compounds against coronavirus progression: preventive effects, mechanistic aspects, and structures, (4) Gastroenteritis: symptoms and epidemiology of SARS-CoV-2, (5) The chronicles of coronavirus: A Chinese king who conquered the entire world, (6) Traditional medicine as a natural remedy in ARDS & COVID-19, (7) Molecular pathogenesis of human coronaviruses of the 21st century, (8) COVID-19, mental health and neuropathophysiology of pain related to temporomandibular disorder. The volume serves as a novel compilation of key data on SARS-CoV-2 and COVID-19 and represents a resource of the utmost value for all scholars studying SARS-CoV infections. It should also be of great interest to clinicians who may be facing an overwhelming number of individuals affected with COVID-19, with over 267 million global cases documented as of the first week of December 2021).

Audience: Researchers, epidemiologists, virologists and healthcare professionals interested in understanding COVID-19 and the virology of SARS-CoV-2.

Contributors

Editor(s):
Jean-Marc Sabatier
Institute of NeuroPhysiopathology
Marseille, Cedex
France




Contributor(s):
Abdel Nasser B. Singab
Department of Pharmacognosy, Faculty of Pharmacy
Ain Shams University
Abbassia, Cairo
Egypt


Aditi Nag
Dr. B. Lal Institute of Biotechnology, Malviya Industrial Area
Malviya Nagar, Jaipur
India


Ahmed E. Elissawy
Department of Pharmacognosy, Faculty of Pharmacy
Ain Shams University
Abbassia, Cairo
Egypt


Aparoop Das
Department of Pharmaceutical Sciences
Dibrugarh University
Dibrugarh - 786004, Assam
India


Heba A.S. El-Nashar
Department of Pharmacognosy, Faculty of Pharmacy
Ain Shams University
Abbassia, Cairo
Egypt


Imran Abdullah
Institute of Nuclear Medicine and Oncology
Lahore
Pakistan


Jyoti Verma
School of Computational and Integrative Sciences
Jawaharlal Nehru University
New Delhi
India


Kalyani Pathak
Department of Pharmaceutical Sciences
Dibrugarh University
Dibrugarh - 786004, Assam
India


Karen Dantur Batista Chaves
Conservative Dentistry Department, Dentistry School
Federal University of Rio Grande do Sul
Porto Alegre
Brazil


Maitreyi Syamala Rajala
School of Biotechnology
Jawaharlal Nehru University
New Delhi
India


Maliha Sarfraz
Department of Zoology, Faculty of Life Sciences
The Women University Multan
Multan
Pakistan


Manash Pratim Pathak
Department of Pharmaceutical Sciences
Dibrugarh University
Dibrugarh - 786004, Assam
India
/
Pratiksha Institute of Pharmaceutical Sciences
Guwahati-781026, Assam
India


Maria Cristina Munerato
Conservative Dentistry Department, Dentistry School
Federal University of Rio Grande do Sul
Porto Alegre
Brazil


Muhammad Ali
Department of Biotechnology
Akhuwat Faisalabad Institute for Research Science and Technology (FIRST)
Faisalabad
Pakistan


Omayma A. Eldahshan
Department of Pharmacognosy, Faculty of Pharmacy
Ain Shams University
Abbassia, Cairo
Egypt


Riya Saikia
Department of Pharmaceutical Sciences
Dibrugarh University
Dibrugarh - 786004, Assam
India


Ruma Karmakar
School of Biotechnology
Jawaharlal Nehru University
New Delhi
India


Sajjad- ur-Rahman
Institute of Microbiology
University of Agriculture
Faisalabad
Pakistan


Sakshi Kumari
School of Biotechnology
Jawaharlal Nehru University
New Delhi
India


Samiullah Sajid
Dali University
Dali, Yunnan
China


Sanaullah Sajid
Institute of Microbiology
University of Agriculture
Faisalabad
Pakistan


Satya Vadlamani
School of Biotechnology
Jawaharlal Nehru University
New Delhi
India


Sonia Sethi
Dr. B. Lal Institute of Biotechnology, Malviya Industrial Area
Malviya Nagar, Jaipur
India


Sheela Angappan
Department of Chemistry
School of Advanced Sciences, Vellore Institute of Technology
Vellore, TN
India


Sudipti Arora
Dr. B. Lal Institute of Biotechnology, Malviya Industrial Area
Malviya Nagar, Jaipur
India


Suresh Kumar Karri
Bioplus Life Sciences, & Radiant Research Bangalore
KA
India


Urvashee Gogoi
Department of Pharmaceutical Sciences
Dibrugarh University
Dibrugarh - 786004, Assam
India


Wafaa A. Hewedy
Department of Clinical Pharmacology, Faculty of Medicine
Alexandria University
Alexandria
Egypt